Cabaletta Bio Ownership | Who Owns Cabaletta Bio?

Cabaletta Bio Ownership Summary

Cabaletta Bio is owned by 22.46% institutional investors, 3.10% insiders, and 74.45% retail investors. Blackrock is the largest institutional shareholder, holding 9.65% of CABA shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 3.81% of its assets in Cabaletta Bio shares.

CABA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cabaletta Bio	22.46%	3.10%	74.45%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.76M	9.65%	$35.58M
T. rowe price investment management	4.07M	8.32%	$9.25M
Adage capital partners gp	3.63M	7.43%	$8.25M
Blackrock funding, inc. /de	3.40M	6.94%	$7.71M
Vanguard group	2.87M	5.86%	$6.51M
Bain capital life sciences investors	2.76M	5.64%	$6.27M
Jennison associates	2.51M	5.13%	$5.70M
Fred alger management	2.32M	4.73%	$5.26M
Point72 asset management	1.27M	2.59%	$2.87M
Geode capital management	1.11M	2.27%	$2.52M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	822.29K	1.62%	$1.87M
Bain capital life sciences investors	2.76M	0.74%	$6.27M
Healthinvest partners ab	247.45K	0.26%	$554.30K
Myda advisors	171.20K	0.10%	$388.62K
Integral health asset management	500.00K	0.10%	$1.14M
Atika capital management	1.00K	0.07%	$748.00K
Aristides capital	75.40K	0.04%	$171.16K
Fred alger management	2.32M	0.03%	$5.26M
Tcg crossover management	86.80K	0.02%	$197.03K
Adage capital partners gp	3.63M	0.01%	$8.25M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	4.76M	0.00%	699.11K
Superstring capital management lp	822.29K	1.62%	690.50K
Point72 asset management	1.27M	0.01%	598.61K
Adage capital partners gp	3.63M	0.01%	597.83K
Two sigma advisers, lp	831.90K	0.00%	550.70K

Top Sellers

Holder	Shares	% Assets	Change
Jennison associates	2.51M	0.00%	-3.12M
Alkeon capital management	-	-	-2.62M
Fred alger management	2.32M	0.03%	-1.80M
Vr adviser	-	-	-1.56M
Sofinnova investments	-	-	-1.53M

New Positions

Holder	Shares	% Assets	Change	Value
Renaissance	230.16K	0.00%	230.16K	$522.47K
Myda advisors	171.20K	0.10%	171.20K	$388.62K
Cantor fitzgerald, l. p.	100.00K	0.00%	100.00K	$224.00K
Thrivent financial for lutherans	95.33K	0.00%	95.33K	$216.00K
Bridgeway capital management	87.67K	0.00%	87.67K	$199.02K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-7.00
Gamma investing	-12.00
Rothschild investment	-25.00
Eversource wealth advisors	-72.00
Capital advisors	-81.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	36	-70.25%	10,990,024	-77.13%	22	0.23%	22	-66.15%	7	-78.79%
Sep 30, 2024	120	-15.49%	48,049,085	-5.40%	98	0.93%	65	-7.14%	33	-32.65%
Jun 30, 2024	142	-14.97%	50,793,811	-0.49%	103	0.96%	70	-21.35%	49	2.08%
Mar 31, 2024	167	22.79%	51,041,400	5.15%	103	0.74%	89	5.95%	48	54.84%
Dec 31, 2023	136	34.65%	48,539,644	18.67%	118	1.37%	84	16.67%	31	158.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Small-Cap Value	1.93M	3.81%	-
Vanguard Total Stock Mkt Idx Inv	1.40M	2.87%	-
PGIM Jennison Health Sciences Z	1.38M	2.82%	-
Vanguard US Total Market Shares ETF	1.40M	2.76%	-
Jennison Health Sciences Equity	1.38M	2.72%	-
Jennison SMid Cap Core Equity	1.29M	2.63%	-
PGIM Jennison Small Company A	1.29M	2.63%	-
iShares Russell 2000 ETF	1.24M	2.44%	-10.72K
T. Rowe Price U.S. SC Value Eq Tr-Z	1.06M	2.17%	4.06K
Alger Small Cap Focus I	1.08M	2.12%	-561.71K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 19, 2024	Binder Gwendolyn	See Remarks	Sell	$14.23K
Jan 19, 2024	Binder Gwendolyn	See Remarks	Sell	$201.21K
Dec 19, 2023	Binder Gwendolyn	See Remarks	Sell	$171.20K
Dec 19, 2023	Binder Gwendolyn	See Remarks	Sell	$69.59K
Nov 20, 2023	Binder Gwendolyn	See Remarks	Sell	$61.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q2	-	-
2024 Q1	-	2
2023 Q4	-	6
2023 Q3	-	6

CABA Ownership FAQ

Who Owns Cabaletta Bio?

Cabaletta Bio shareholders are primarily institutional investors at 22.46%, followed by 3.10% insiders and 74.44% retail investors. The average institutional ownership in Cabaletta Bio's industry, Biotech Stocks , is 68.48%, which Cabaletta Bio falls below.

Who owns the most shares of Cabaletta Bio?

Cabaletta Bio’s largest shareholders are Blackrock (4.76M shares, 9.65%), T. rowe price investment management (4.07M shares, 8.32%), and Adage capital partners gp (3.63M shares, 7.43%). Together, they hold 25.40% of Cabaletta Bio’s total shares outstanding.

Does Blackrock own Cabaletta Bio?

Yes, BlackRock owns 9.65% of Cabaletta Bio, totaling 4.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.58M$. In the last quarter, BlackRock increased its holdings by 699.11K shares, a 17.23% change.

Who is Cabaletta Bio’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cabaletta Bio’s biggest shareholder by percentage of total assets invested, with 1.62% of its assets in 822.29K Cabaletta Bio shares, valued at 1.87M$.

Who is the top mutual fund holder of Cabaletta Bio shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Cabaletta Bio shares, with 3.81% of its total shares outstanding invested in 1.93M Cabaletta Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools